ArticleEuropean journal of immunology2012

A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.

Austin Pantel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.